UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 17, 2017 5:00 P.M.

Form:	S-3
CIK: 0001427570 Company Name: OBALON THERAPEUTICS INC File Number: 333-221264